UNSPSC 51191584: Indapamide + perindopril terbutylamine

Perindopril works by inhibiting the formation of hormones that raise blood pressure (ACE inhibitor), while indapamide increases the elimination of salt and water through the kidneys.

UNSPSC 51191584 Indapamide + perindopril terbutylamine is a Commodity code with minimal recent state and local procurement activity aligned to its pharmaceutical scope. The single relevant opportunity on record is the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and over-the-counter products, posted January 20, 2026, with proposals due March 26, 2026. That solicitation sought manufacturers to supply comprehensive pricing across identified pharmaceutical products with specific National Drug Codes through authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), with awarded vendors effective July 1, 2026. A second recent opportunity—the City of Meriden's bid for sodium bisulfite chemical supply (solicitation B027-15, due July 29, 2026)—is unrelated to the code's pharmaceutical scope and appears to be miscoded in the source.

The MMCAP RFP is the operative signal for pharmaceutical procurement under this code. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, procures on behalf of participating state and local government facilities including Oregon. Vendors must certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, maintain contractual relationships with at least two of the three authorized wholesalers, and carry commercial general liability of $5,000,000 per occurrence and professional liability of $2,000,000. Evaluation weights price competitiveness at 75 percent, fixed pricing at 10 percent, and compliance with administrative fees, EDI capability, and data format requirements at 5 percent each. The contract runs two years for new responders with optional MMCAP extensions, or aligns to incumbent expiration dates through June 30, 2028. No specific award value or budget range is disclosed; vendors pay a 3 percent administrative fee on all purchases and face performance penalties of $200 to $1,500 per violation.